S, C., A, M., J, Y., LA, C., J, I., R, C., . . . R, K. (2021). Selective targeting of NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in rodents. Science translational medicine, 13(619), eabh1314. https://doi.org/10.1126/scitranslmed.abh1314
Chicago Style (17th ed.) CitationS, Cai, et al. "Selective Targeting of NaV1.7 via Inhibition of the CRMP2-Ubc9 Interaction Reduces Pain in Rodents." Science Translational Medicine 13, no. 619 (2021): eabh1314. https://doi.org/10.1126/scitranslmed.abh1314.
MLA (9th ed.) CitationS, Cai, et al. "Selective Targeting of NaV1.7 via Inhibition of the CRMP2-Ubc9 Interaction Reduces Pain in Rodents." Science Translational Medicine, vol. 13, no. 619, 2021, p. eabh1314, https://doi.org/10.1126/scitranslmed.abh1314.